Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines

Inclusion Criteria: * Subjects ≥18 years of age based on the date of the written informed consent form. * Subject is able to provide written informed consent and comply with study procedures. * Subject has moderate or severe glabellar lines on maximum frown as assessed by the investigator and subject using the GLS (score of 2 or 3). Exclusion Criteria: * Previous insertion of permanent material in the glabellar area including the forehead. * Planned treatment with botulinum toxin of any serotype in any other body region during the study period. * Pregnant or breastfeeding (directly or via pump); or planning to become pregnant during the study. * Known allergy or hypersensitivity to botulinum toxin or product excipients. * Participation in another interventional clinical study ≤30 days of Visit 1: Screening. * Planning to donate, bank, or retrieve eggs (ova, oocytes) or donate sperm during the study.